PBH - Prestige Consumer Healthcare Inc.
Close
79.115
0.185 0.234%
Share volume: 4,559
Last Updated: Thu 26 Dec 2024 08:26:42 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$78.93
0.18
0.23%
Fundamental analysis
66%
Profitability
48%
Dept financing
42%
Liquidity
69%
Performance
90%
Performance
5 Days
0.24%
1 Month
-5.33%
3 Months
10.37%
6 Months
14.30%
1 Year
27.57%
2 Year
26.98%
Key data
Stock price
$79.12
DAY RANGE
$78.10 - $79.34
52 WEEK RANGE
$58.95 - $86.36
52 WEEK CHANGE
$27.39
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Ronald M. Lombardi
Region: US
Website: prestigebrands.com
Employees: 540
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: prestigebrands.com
Employees: 540
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Prestige Consumer Healthcare Inc. develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies.
Recent news